Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trialLai Xu, Lei Chen, Bo Feng et al.|The Lancet Oncology|2021Cited by 184
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinibAdam S. Kittai, Jennifer A. Woyach, Cecelia Miller et al.|Blood|2021Cited by 61
Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter AnalysisAdam S. Kittai, Alexey V. Danilov, Ying Huang et al.|Transplantation and Cellular Therapy|2020Cited by 60
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective StudyAdam S. Kittai, Philip A. Thompson, David A. Bond et al.|Journal of Clinical Oncology|2024Cited by 43
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A. Herbst, Sascha Dietrich, Mattias Vesterlund et al.|Nature Communications|2022Cited by 42